FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080496045> ?p ?o ?g. }

• W3080496045 endingPage "2294" @default.
• W3080496045 startingPage "2287" @default.
• W3080496045 abstract "Abstract Background: B-cell activating factor (BAFF) is vital for B cell survival. Serum BAFF levels are elevated in thrombotic antiphospholipid syndrome, but little is known about levels in patients with positive antiphospholipid antibodies (aPLs) and previous adverse pregnancy outcomes (APOs). We aimed to analyze serum BAFF concentrations of these patients in early pregnancy along with different pregnancy outcomes. Methods: Thirty-six pregnant patients positive for aPLs and previous APOs (patient group), 25 healthy pregnant females (HP group) and 35 healthy non-pregnant females (HNP group) from the Peking University Third Hospital, between October 2018 and March 2019, were enrolled in this study. Serum of HNP and serum of patients as well as HP in the first gestational trimester were collected. Enzyme-linked immunosorbent assay kits were used to measure serum BAFF and interferon-alpha (IFN-α) concentrations. Cytometric bead array analysis was used to measure serum concentrations of cytokines. The patient group was further divided into APOs and non-APOs (NAPOs) group, fetal loss and live birth group according to pregnancy outcomes. The Mann-Whitney U -test was used to assess significance between and within groups. Spearman rank-order was used to evaluate correlation coefficients between BAFF and related cytokines. Results: The serum BAFF level in HP group was significantly lower than HNP group (245.24 [218.80, 265.90] vs . 326.94 [267.31, 414.80] pg/mL, Z = −3.966, P < 0.001). The BAFF level was obviously elevated in patient group compared to that in HP group (307.77 [219.86, 415.65] vs . 245.24 [218.80, 265.90] pg/mL, Z = −2.464, P = 0.013). BAFF levels in APOs group tended to be higher than that in NAPOs group (416.52 [307.07, 511.12] vs . 259.37 [203.59, 375.81] pg/mL, Z = −2.718, P = 0.006). Compared to HP group, concentrations of IFN-α, interleukin (IL-6) and tumor necrosis factor were higher in patient group (33.37 [18.85, 48.12] vs . 13.10 [6.85, 25.47] pg/mL, Z = −2.023, P = 0.043; 39.16 [4.41, 195.87] vs . 3.37 [2.92, 3.90] pg/mL, Z = −3.650 , P < 0.001; 8.23 [2.27, 64.46] vs . 1.53 [1.25, 2.31] pg/mL, Z = −3.604, P < 0.001, respectively). Serum BAFF levels had a positive correlation with the concentrations of both IL-6 and IL-10 (IL-6: r = 0.525, P = 0.002; IL-10: r = 0.438, P = 0.012). Conclusions: Serum BAFF levels are increased in patients with positive aPLs and previous APOs as compared to healthy pregnant females and tend to be higher in individuals with current APOs. The BAFF levels have a positive correlation with serum IL-6 and IL-10." @default.
• W3080496045 created "2020-09-01" @default.
• W3080496045 creator A5022058097 @default.
• W3080496045 creator A5032748496 @default.
• W3080496045 creator A5056901189 @default.
• W3080496045 creator A5075668227 @default.
• W3080496045 date "2020-08-24" @default.
• W3080496045 modified "2023-10-17" @default.
• W3080496045 title "Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance" @default.
• W3080496045 cites W1436381384 @default.
• W3080496045 cites W1978302597 @default.
• W3080496045 cites W1982924102 @default.
• W3080496045 cites W1993674320 @default.
• W3080496045 cites W1995025510 @default.
• W3080496045 cites W1998537704 @default.
• W3080496045 cites W2005068507 @default.
• W3080496045 cites W2019990958 @default.
• W3080496045 cites W2049278423 @default.
• W3080496045 cites W2049858255 @default.
• W3080496045 cites W2054330426 @default.
• W3080496045 cites W2104769463 @default.
• W3080496045 cites W2111101543 @default.
• W3080496045 cites W2115953810 @default.
• W3080496045 cites W2136590857 @default.
• W3080496045 cites W2264962945 @default.
• W3080496045 cites W2322139300 @default.
• W3080496045 cites W2329620654 @default.
• W3080496045 cites W2403072297 @default.
• W3080496045 cites W2558713792 @default.
• W3080496045 cites W2766476830 @default.
• W3080496045 cites W2884213248 @default.
• W3080496045 cites W2906378278 @default.
• W3080496045 cites W2911075960 @default.
• W3080496045 cites W2915615482 @default.
• W3080496045 cites W2917728585 @default.
• W3080496045 cites W2948493831 @default.
• W3080496045 doi "https://doi.org/10.1097/cm9.0000000000000948" @default.
• W3080496045 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7546878" @default.
• W3080496045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32842014" @default.
• W3080496045 hasPublicationYear "2020" @default.
• W3080496045 type Work @default.
• W3080496045 sameAs 3080496045 @default.
• W3080496045 citedByCount "4" @default.
• W3080496045 countsByYear W30804960452021 @default.
• W3080496045 countsByYear W30804960452022 @default.
• W3080496045 crossrefType "journal-article" @default.
• W3080496045 hasAuthorship W3080496045A5022058097 @default.
• W3080496045 hasAuthorship W3080496045A5032748496 @default.
• W3080496045 hasAuthorship W3080496045A5056901189 @default.
• W3080496045 hasAuthorship W3080496045A5075668227 @default.
• W3080496045 hasBestOaLocation W30804960451 @default.
• W3080496045 hasConcept C126322002 @default.
• W3080496045 hasConcept C131872663 @default.
• W3080496045 hasConcept C159654299 @default.
• W3080496045 hasConcept C170286685 @default.
• W3080496045 hasConcept C197934379 @default.
• W3080496045 hasConcept C203014093 @default.
• W3080496045 hasConcept C2777785397 @default.
• W3080496045 hasConcept C2778376644 @default.
• W3080496045 hasConcept C2778453870 @default.
• W3080496045 hasConcept C2779234561 @default.
• W3080496045 hasConcept C54355233 @default.
• W3080496045 hasConcept C71924100 @default.
• W3080496045 hasConcept C86803240 @default.
• W3080496045 hasConcept C90924648 @default.
• W3080496045 hasConceptScore W3080496045C126322002 @default.
• W3080496045 hasConceptScore W3080496045C131872663 @default.
• W3080496045 hasConceptScore W3080496045C159654299 @default.
• W3080496045 hasConceptScore W3080496045C170286685 @default.
• W3080496045 hasConceptScore W3080496045C197934379 @default.
• W3080496045 hasConceptScore W3080496045C203014093 @default.
• W3080496045 hasConceptScore W3080496045C2777785397 @default.
• W3080496045 hasConceptScore W3080496045C2778376644 @default.
• W3080496045 hasConceptScore W3080496045C2778453870 @default.
• W3080496045 hasConceptScore W3080496045C2779234561 @default.
• W3080496045 hasConceptScore W3080496045C54355233 @default.
• W3080496045 hasConceptScore W3080496045C71924100 @default.
• W3080496045 hasConceptScore W3080496045C86803240 @default.
• W3080496045 hasConceptScore W3080496045C90924648 @default.
• W3080496045 hasIssue "19" @default.
• W3080496045 hasLocation W30804960451 @default.
• W3080496045 hasLocation W30804960452 @default.
• W3080496045 hasLocation W30804960453 @default.
• W3080496045 hasLocation W30804960454 @default.
• W3080496045 hasOpenAccess W3080496045 @default.
• W3080496045 hasPrimaryLocation W30804960451 @default.
• W3080496045 hasRelatedWork W1482616571 @default.
• W3080496045 hasRelatedWork W1801771134 @default.
• W3080496045 hasRelatedWork W1966101413 @default.
• W3080496045 hasRelatedWork W1994197612 @default.
• W3080496045 hasRelatedWork W2121472925 @default.
• W3080496045 hasRelatedWork W2135668656 @default.
• W3080496045 hasRelatedWork W2159864982 @default.
• W3080496045 hasRelatedWork W2159917672 @default.
• W3080496045 hasRelatedWork W2518723645 @default.
• W3080496045 hasRelatedWork W2056910410 @default.
• W3080496045 hasVolume "133" @default.
• W3080496045 isParatext "false" @default.

• next